Pancreatic Cancer News and Research

RSS

Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.

Using the immune system to fight cancer: an interview with Dr Charles Akle

We all produce as many as 100,000 different types of cancer cells every day, which are recognized and eliminated by our extraordinarily efficient immune system. However, if something goes wrong with the immune system, and it no longer gets rid of these cells, then that’s when cancerous cells grow and become a problem.

12 Sep 2016

Study opens door to new class of therapies for Ras-dependent cancers

New research from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai identifies a protein that may be an unexplored target to develop new cancer therapies.

9 Sep 2016

Virginia Mason offers totally laparoscopic advanced surgery for removing tumors from pancreas

Virginia Mason now offers the totally laparoscopic Whipple procedure as an advanced surgical option for removing tumors from the head of the pancreas.

9 Sep 2016

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

8 Sep 2016

Schizophrenia drug slows pancreatic tumor growth in mice

A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer -- and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at McGill University and the German Cancer Research Center.

7 Sep 2016

New drug holds potential for treating advanced mastocytosis

Most people have never heard of mastocytosis. It's a rare, sometimes deadly, immune disorder. Now new research may help those with advanced mastocytosis and possibly many more people, too.

6 Sep 2016

Newly-developed epigenetic test can be used to identify tumors responsible for metastasis in cancer patient

In patients with cancer, initial diagnosis most often includes the detection of the primary or original tumor and the presence or absence of metastases, ie cells from the original tumor that have escaped from their original location and are growing into other tissues of the patient.

27 Aug 2016

UCSF researchers identify new strategy to cultivate beneficial energy-burning fat

UC San Francisco researchers studying beige fat — a calorie-burning tissue that can help to ward off obesity and diabetes — have discovered a new strategy to cultivate this beneficial blubber.

25 Aug 2016

Curbing immune system infighting could make treatment more effective for pancreatic cancer

Internal conflict between cell types explains why the immune system struggles to recognize and attack pancreatic cancer.

25 Aug 2016

Interpace Diagnostics introduces new AccuCEA Insights for diagnosing and treating pancreatic cancer

Interpace Diagnostics Group, a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for better patient diagnosis and management, reported today that the Company has launched a new version of their AccuCEA™ product called "Insights" for Gastroenterologists who focus on diagnosing and treating pancreatic cancer.

24 Aug 2016

Novel marine natural product appears to reduce pancreatic tumor size

Scientists at Florida Atlantic University's Harbor Branch Oceanographic Institute found that a deep-water marine sponge collected off of Fort Lauderdale's coast contains leiodermatolide, a natural product that has the ability to inhibit the growth of cancer cells as well as block cancer cells from dividing using extremely low concentrations of the compound.

18 Aug 2016

NIH funds collaborative project to develop better vaccine adjuvants for many diseases

Dr. Qizhi Cathy Yao, professor of surgery, molecular virology and microbiology, and pathology & immunology at Baylor College of Medicine, has been awarded a National Institutes of Health grant to fund a collaborative project with Molecular Express, Inc.

12 Aug 2016

Pancreatic cancer cells find alternative source of nutrition to avoid starvation

Pancreatic cancer cells avert starvation in dense tumors by ordering nearby support cells to supply them with an alternative source of nutrition.

11 Aug 2016

SBP board member donates $1M for researchers to study pancreatic and prostate cancer

Sanford Burnham Prebys Medical Discovery Institute (SBP) has received a $1M donation from The Epstein Family Foundation for scientists to study pancreatic and prostate cancer.

10 Aug 2016

Immunotherapy drug combination shows prominent therapeutic effect against advanced and metastatic cancers in mice

A drug combination designed to enhance the immune system's ability to zero in and attack cancer cells has shown a pronounced therapeutic effect against advanced and metastatic cancers in mice, according to a Mayo Clinic study, published in the July 12 edition of the online journal Oncotarget.

12 Jul 2016

Pancreatic cysts increase overall risk of pancreatic cancer, study shows

A look back at more than half a million patient records has established that patients with pancreatic cysts have a significantly higher overall risk of pancreatic cancer compared to those without such cysts, according to a study in the July issue of GIE: Gastrointestinal Endoscopy, the journal of the American Society for Gastrointestinal Endoscopy.

12 Jul 2016

Pancreatic Cancer News and Research

Further Reading

Using the immune system to fight cancer: an interview with Dr Charles Akle

Study opens door to new class of therapies for Ras-dependent cancers

Virginia Mason offers totally laparoscopic advanced surgery for removing tumors from pancreas

New immunotherapy treatment may offer hope for many pancreatic cancer patients

Schizophrenia drug slows pancreatic tumor growth in mice

New drug holds potential for treating advanced mastocytosis

Newly-developed epigenetic test can be used to identify tumors responsible for metastasis in cancer patient

UCSF researchers identify new strategy to cultivate beneficial energy-burning fat

Curbing immune system infighting could make treatment more effective for pancreatic cancer

Interpace Diagnostics introduces new AccuCEA Insights for diagnosing and treating pancreatic cancer

Novel marine natural product appears to reduce pancreatic tumor size

NIH funds collaborative project to develop better vaccine adjuvants for many diseases

Pancreatic cancer cells find alternative source of nutrition to avoid starvation

SBP board member donates $1M for researchers to study pancreatic and prostate cancer

Immunotherapy drug combination shows prominent therapeutic effect against advanced and metastatic cancers in mice

Pancreatic cysts increase overall risk of pancreatic cancer, study shows

Researchers discover new signaling events that trigger metastasis in ovarian cancer cells

MGH researchers discover how obesity increases inflammation, desmoplasia in PDAC patients

Immunotherapy in conjunction with drugs could be effective in treating pancreatic cancer

Vitamin D sufficiency linked to better pancreatic cancer survival

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News